PolyNovo Chairman, David Williams, said, “While the burn trial was ultimately not needed for ARTG or CE approval, the excellent results, while expected, will strengthen our marketing to surgeons worldwide.”
PolyNovo Chairman, David Williams, said, “While the burn trial...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.61 |
Change
-0.030(1.14%) |
Mkt cap ! $1.802B | |||
| Open | High | Low | Value | Volume |
| $2.63 | $2.64 | $2.57 | $2.471M | 949.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3653 | $2.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.61 | 15489 | 5 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |